Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Wong Siu Hong Alfred Co funder of Noel Gifts|
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Director of Noel Gifts Int'l Ltd, Alfred Wong, shares the story behind Noel success.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Aspen Group: Navigating the Affordable Accommodation Sector Amidst Economic Shifts|CEO , Aspen Group Ltd
00:10:00
Panel Discussion: Maintaining a Diverse Leadership Pipeline | Tom Monahan - Chief Executive Officer of Heidrick & Struggles
00:10:00
Dundee Precious Metals: Expanding Horizons in Precious Metals Production
00:00:00
Shield Therapeutics' present drive for US launch success of iron deficiency product Accrufer - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Honouring Women in Franchising | Susan Senecal, CEO , A&W Revenue Royalties Income Fund.
00:10:00
Key Considerations for Investors Evaluating CLOs: Insights from Oaktree's Structured Credit Experts
00:10:00
Driving Growth and Innovation: Insights from Paolo Martini | Paolo Martini, CEO , Azimut Holding.
00:10:00
Henderson Land Honored in Singapore with Second 'Developer of the Year' Award|Mr Yu Ching Yan Johnny,Advisor to Chairman,Henderson Land Development Co. Ltd.
00:10:00
Hank Smith, Haverford Trust director and co-CIO, and Broadcom CEO Hock Tan discussed Apple Inc. and business trends on CNBC's "Mad Money."
00:10:00
At the 25 Years MCI event, Christoph Vilanek of freenet AG and Thierry Bernard, CEO of QIAGEN N.V., engage in a distinguished guest live talk.
00:10:00
Phoenix Group CEO Andy Briggs discusses earnings, cash generation, and M&A outlook as the company pivots towards growth.
00:10:00
London Security plc was incorporated in 1897 but operated as an engineering company. In the 1980’s, the activity was amended to that of a property investment company | Emmanuel Sebag,Executive Director,London Security Plc